Skip to main content

Rockefeller University Head Levine Steps Down as Inquiry Unfolds

For an updated version of this story, click here.

 

NEW YORK, Feb. 11 - Rockefeller University President Arnold J. Levine announced on Sunday that he is resigning his post immediately due to health reasons, The New York Times reports on Monday.

"In recent weeks, I have become aware of matters affecting my own personal health that I need to address immediately," Levine said in a statement released by the university. "In light of my health issues, I regret I will not be able to continue to lead this extraordinary institution and these talented people."

 

Richard B. Fisher, the school's chairman, said in a statement that the board had accepted Levine's decision "with understanding and compassion," and that the trustees would appoint an acting president soon and start a search for a new president immediately, according to the Times report.

Levine's abrupt departure comes on the heels of questioning by Rockefeller's trustees into an alleged encounter in January between Levine and an adult female student that occurred in a campus lounge when both were drunk, according to people close to the former president, who spoke to the Times on the condition of anonymity.

These people said that although the student said the encounter had been consensual, Levine had said it was inappropriate. These people went on to say that after discussing the incident with Fisher, Levine volunteered to step down. He remains as a faculty member and director of a research laboratory, but will take time off.

The university said last night that Levine was not available for comment.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.